Efficacy and Safety of Perampanel as Early Adjunctive Therapy in Chinese Patients with Partial Onset Seizures - The Interim Analysis

被引:0
作者
Gao, Lehong [1 ]
Wang, Yuping [1 ]
Lu, Qiang [2 ]
Wang, Guoping [3 ]
Wang, Zan [4 ]
Yue, Wei [5 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Anhui Prov Hosp, Hefei, Anhui, Peoples R China
[4] Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China
[5] Tianjin Huanhu Hosp, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S149
引用
收藏
页码:S89 / S89
页数:1
相关论文
共 50 条
[21]   Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures [J].
Baulac, Michel ;
Leppik, Iio E. .
EPILEPSY RESEARCH, 2007, 75 (2-3) :75-83
[22]   Zonisamide as Adjunctive Therapy for Adults with Partial-Onset Epileptic Seizures: An Efficacy and Safety Review [J].
Vossler, David G. .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 :331-339
[23]   A Multicenter, Randomized Phase III Trial Evaluating the Efficacy and Safety of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures [J].
Krauss, Gregory L. ;
Serratosa, Jose M. ;
Villanueva, Vicente E. ;
Endziniene, Milda ;
Hong, Zhen ;
French, Jacqueline ;
Yang, Haichen ;
Squillacote, David ;
Zhu, Jin ;
Laurenza, Antonio .
NEUROLOGY, 2011, 76 (09) :A615-A615
[24]   Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies [J].
Steinhoff, Bernhard J. ;
Ben-Menachem, Elinor ;
Ryvlin, Philippe ;
Shorvon, Simon ;
Kramer, Lynn ;
Satlin, Andrew ;
Squillacote, David ;
Yang, Haichen ;
Zhu, Jin ;
Laurenza, Antonio .
EPILEPSIA, 2013, 54 (08) :1481-1489
[25]   PERPRISE (PERampanel in patients with PRImary or SEcondarily generalised seizures): first interim analysis of the observational study assessing perampanel as the only adjunctive therapy [J].
Steinhoff, B. J. ;
Goldmann, T. ;
Winter, Y. .
EPILEPSIA, 2023, 64 :295-295
[26]   Determination of Tolerability, Safety, and Efficacy of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Subjects with Refractory Partial Seizures [J].
Krauss, Gregory L. ;
Biton, Victor ;
Klapper, Jack A. ;
Bar, Michael ;
Rektor, Ivan ;
Vaiciene-Magistris, Nerija ;
Skaringa, Algimantas ;
Liigant, Aive ;
Kumar, Dinesh ;
Squillacote, David .
NEUROLOGY, 2009, 72 (11) :A442-A442
[27]   DETERMINATION OF TOLERABILITY, SAFETY, AND EFFICACY OF PERAMPANEL, A SELECTIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN SUBJECTS WITH REFRACTORY PARTIAL SEIZURES [J].
Krauss, G. ;
Biton, V. ;
Klapper, J. ;
Bar, M. ;
Rektor, I. ;
Vaiciene-Magistris, N. ;
Liigant, A. ;
Kumar, D. ;
Squillacote, D. .
EPILEPSIA, 2009, 50 :103-103
[28]   PerampanelAs Adjunctive Therapy in Patients with Partial-Onset Seizures [J].
Greg L. Plosker .
CNS Drugs, 2012, 26 :1085-1096
[29]   Efficacy and safety of rufinamide as adjunctive therapy for inadequately controlled partial seizures in pediatric patients [J].
Glauser, T ;
Arzimanoglou, A ;
Litzinger, M ;
Frank, LM ;
Vigevano, F ;
Perdomo, C ;
Arroyo, S .
EPILEPSIA, 2005, 46 :194-195
[30]   Efficacy and safety of rufinamide as adjunctive therapy in adult patients with inadequately controlled partial seizures [J].
Brodie, MJ ;
Rosenfeld, W ;
Vazquez, B ;
Ko, D ;
Perdomo, C ;
Arroyo, S .
NEUROLOGY, 2006, 66 (05) :A35-A36